NPR

FDA Approves First Digital Pill That Can Track If You've Taken It

Abilify MyCite is a tablet with an embedded sensor activated by fluid in the stomach. Although the drug's approval is a big step for digital medicine, there are concerns about privacy and cost.
The FDA has approved the first drug with "a digital ingestion tracking system." Abilify MyCite is an antipsychotic with an ingestible sensor that transmits data to a patch, which then sends the information to a smartphone app.

The Food and Drug Administration has approved its first digital drug: a pill embedded with a sensor that transmits whether someone has taken it.

Although the approval is a big step for digital medicine, there are concerns about privacy, convenience and cost.

The tablet and embedded sensor is called Abilify MyCite. Abilify, made by Japan-based Otsuka Pharmaceutical, is the brand-name version of , an antipsychotic drug used for treating schizophrenia, bipolar disorder and as an

You’re reading a preview, subscribe to read more.

More from NPR

NPR5 min readWorld
When Rockets Fall, Some Israeli Citizens Have Nowhere To Hide
While most buildings in Israel are required to have bomb shelters, a zoning catch-22 has left Bedouin villagers unprotected.
NPR3 min read
Renowned Painter And Pioneer Of Minimalism Frank Stella Dies At 87
Frank Stella was one of America's leading minimalist artists and a pioneer of the minimalist movement of the early 1960s. The movement challenged the idea that art was meant to be representative.
NPR2 min read
A Seafood Bounty Lures Sea Lions To S.F.'s Pier 39 In Numbers Not Seen In 15 Years
It's a popular rest stop for sea lions, but the docks at the tourist hot spot these days are unusually packed out with the slippery residents. Conservationists are buoyed by the surge in visitors.

Related Books & Audiobooks